Teladoc Health Inc (TDOC) Shares Bought by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC raised its holdings in Teladoc Health Inc (NYSE:TDOC) by 6.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 117,955 shares of the health services provider’s stock after purchasing an additional 7,100 shares during the period. Motley Fool Asset Management LLC’s holdings in Teladoc Health were worth $6,558,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Bainco International Investors raised its position in shares of Teladoc Health by 10.1% in the first quarter. Bainco International Investors now owns 131,936 shares of the health services provider’s stock valued at $7,336,000 after buying an additional 12,084 shares during the last quarter. Trustcore Financial Services LLC raised its position in shares of Teladoc Health by 100.0% in the first quarter. Trustcore Financial Services LLC now owns 800 shares of the health services provider’s stock valued at $44,000 after buying an additional 400 shares during the last quarter. Raymond James & Associates increased its position in Teladoc Health by 16.2% during the first quarter. Raymond James & Associates now owns 213,732 shares of the health services provider’s stock worth $11,883,000 after purchasing an additional 29,746 shares during the last quarter. Seelaus Asset Management LLC acquired a new position in Teladoc Health during the first quarter worth approximately $213,000. Finally, Toronto Dominion Bank acquired a new position in Teladoc Health during the first quarter worth approximately $1,587,000.

Several equities analysts recently commented on TDOC shares. Zacks Investment Research raised shares of Teladoc Health from a “sell” rating to a “hold” rating in a research report on Saturday, January 26th. Berenberg Bank started coverage on shares of Teladoc Health in a research report on Thursday, January 31st. They set a “buy” rating and a $80.00 price target for the company. TheStreet raised shares of Teladoc Health from a “d+” rating to a “c” rating in a research report on Wednesday, February 20th. Cantor Fitzgerald reaffirmed a “hold” rating and set a $70.00 price target (down previously from $83.00) on shares of Teladoc Health in a research report on Wednesday, February 27th. Finally, SunTrust Banks upped their price target on shares of Teladoc Health to $75.00 and gave the stock a “positive” rating in a research report on Monday, March 4th. Four equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $81.00.

Teladoc Health stock opened at $61.35 on Friday. Teladoc Health Inc has a 52-week low of $42.08 and a 52-week high of $89.05. The firm has a market capitalization of $4.39 billion, a PE ratio of -42.60 and a beta of 1.38. The company has a quick ratio of 7.54, a current ratio of 7.54 and a debt-to-equity ratio of 0.42.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 27th. The health services provider reported ($0.35) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.35). Teladoc Health had a negative net margin of 22.63% and a negative return on equity of 10.86%. The company had revenue of $122.74 million during the quarter, compared to analyst estimates of $120.19 million. Research analysts anticipate that Teladoc Health Inc will post -1.53 EPS for the current fiscal year.

In other news, CEO Jason N. Gorevic sold 30,000 shares of the company’s stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $69.68, for a total value of $2,090,400.00. Following the completion of the transaction, the chief executive officer now directly owns 631,875 shares in the company, valued at $44,029,050. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Andrew Turitz sold 31,960 shares of the company’s stock in a transaction on Thursday, April 4th. The shares were sold at an average price of $55.82, for a total transaction of $1,784,007.20. Following the completion of the transaction, the senior vice president now owns 13,455 shares of the company’s stock, valued at $751,058.10. The disclosure for this sale can be found here. Insiders sold 179,005 shares of company stock valued at $10,813,875 in the last three months. Company insiders own 3.95% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/05/17/teladoc-health-inc-tdoc-shares-bought-by-motley-fool-asset-management-llc.html.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: How is the LIBOR rate calculated?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.